Arterra Bioscience SpA (IT:ARBS)
:ARBS
Total Valuation
Arterra Bioscience SpA has a market cap or net worth of €18.84M. The enterprise value is €17.29M.
Market Cap€18.84M
Enterprise Value€17.29M
Share Statistics
Arterra Bioscience SpA has 6,658,493 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,658,493
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Arterra Bioscience SpA’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 4.29%.
Return on Equity (ROE)0.16
Return on Assets (ROA)0.14
Return on Invested Capital (ROIC)4.29%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee154.98K
Profits Per Employee66.88K
Employee Count30
Asset Turnover0.32
Inventory Turnover2.54
Valuation Ratios
The current PE Ratio of Arterra Bioscience SpA is 9.4. Arterra Bioscience SpA’s PEG ratio is 0.20.
PE Ratio9.4
PS Ratio4.32
PB Ratio1.60
Price to Fair Value1.60
Price to FCF13.07
Price to Operating Cash Flow9.46
PEG Ratio0.20
Income Statement
In the last 12 months, Arterra Bioscience SpA had revenue of 4.65M and earned 2.01M in profits. Earnings per share was 0.30.
Revenue4.65M
Gross Profit737.89K
Operating Income591.76K
Pretax Income2.00M
Net Income2.01M
EBITDA881.95K
Earnings Per Share (EPS)0.30
Cash Flow
In the last 12 months, operating cash flow was 1.99M and capital expenditures -453.29K, giving a free cash flow of 1.54M billion.
Operating Cash Flow1.99M
Free Cash Flow1.54M
Free Cash Flow per Share0.23
Dividends & Yields
Arterra Bioscience SpA pays an annual dividend of €0.15, resulting in a dividend yield of 4.33%
Dividend Per Share€0.15
Dividend Yield4.33%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.32
52-Week Price Change29.40%
50-Day Moving Average2.89
200-Day Moving Average2.83
Relative Strength Index (RSI)49.46
Average Volume (3m)55.55K
Important Dates
Arterra Bioscience SpA upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Arterra Bioscience SpA as a current ratio of 7.74, with Debt / Equity ratio of 2.07%
Current Ratio7.74
Quick Ratio5.99
Debt to Market Cap0.01
Net Debt to EBITDA-1.23
Interest Coverage Ratio667.15
Taxes
In the past 12 months, Arterra Bioscience SpA has paid -8.49K in taxes.
Income Tax-8.49K
Effective Tax Rate>-0.01
Enterprise Valuation
Arterra Bioscience SpA EV to EBITDA ratio is 21.57, with an EV/FCF ratio of 12.36.
EV to Sales4.09
EV to EBITDA21.57
EV to Free Cash Flow12.36
EV to Operating Cash Flow9.55
Balance Sheet
Arterra Bioscience SpA has €1.34M in cash and marketable securities with €260.35K in debt, giving a net cash position of €1.08M billion.
Cash & Marketable Securities€1.34M
Total Debt€260.35K
Net Cash€1.08M
Net Cash Per Share€0.16
Tangible Book Value Per Share€1.89
Margins
Gross margin is 15.87%, with operating margin of 12.73%, and net profit margin of 43.15%.
Gross Margin15.87%
Operating Margin12.73%
Pretax Margin42.97%
Net Profit Margin43.15%
EBITDA Margin18.97%
EBIT Margin12.73%
Analyst Forecast
The average price target for Arterra Bioscience SpA is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast11.42%
EPS Growth Forecast50.12%